Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Generex Biotechnology Corporatio (GNBT)

Generex Biotechnology Corporatio (GNBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Generex Biotechnology Corporatio 10102 USA TODAY WAY MIRAMAR FL 33025 USA

P: 416-364-2551

Description:

Generex Biotechnology Corporation provides research, development, and commercialization of drug delivery systems and technologies. The company's products include Generex Oral-lyn, Glucose RapidSpray, BaBOOM Energy Spray and Crave-NX. It markets its products primarily in Ecuador, Canada, and the United States. Generex Biotechnology Corporation is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 26,145
Shares Outstanding, K 108,984
Annual Sales, $ 2,660 K
Annual Net Income, $ -33,340 K
Last Quarter Sales, $ 580 K
Last Quarter Net Income, $ -11,670 K
60-Month Beta -2.78
% of Insider Shareholders 35.20%
% of Institutional Shareholders 0.02%
Float, K 70,622
% Float 64.80%

Growth:

1-Year Return -0.04%
3-Year Return 1,261.59%
5-Year Return 411.09%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 12/21/20
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year -40.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 140-100 on 02/25/20

GNBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -44.66
Price/Earnings to Growth N/A
Return-on-Equity % -1,712.86%
Return-on-Assets % -52.66%
Profit Margin % -1,253.38
Net Margin % -3,946.14
Debt/Equity N/A
Price/Sales 9.01
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.10
Interest Coverage -3.82
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar